# Safety and Efficacy of Furosemide 40mg + Amiloride Hydrochloride 10mg to Reduct Edema

> **NCT01210365** · PHASE3 · TERMINATED · sponsor: **Eurofarma Laboratorios S.A.** · enrollment: 27 (actual)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DRUG:** Diurisa®
- **DRUG:** Lasix ®

## Key facts

- **NCT ID:** NCT01210365
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01-01
- **Primary completion:** 2013-03-01
- **Final completion:** 2013-03
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** EF decided suspended the study because the investigational product was changed.
- **Last updated:** 2022-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01210365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01210365, "Safety and Efficacy of Furosemide 40mg + Amiloride Hydrochloride 10mg to Reduct Edema". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01210365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*